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LA cmvIL-10Human cytomegalovirus (HCMV) expresses several homologues of human interleukin 10 (hIL-10) possessing
immunomodulatory propertieswhichmaypromote viral infection bymodulating the function ofmyeloid cells.
We examined the phenotype and phagocytic capability of human monocytes exposed to hIL-10, an HCMV-
encoded hIL-10 homologue expressed during the productive phase of infection (cmvIL-10), and a differentially
spliced form of cmvIL-10 expressed during latent and productive phases of infection, (LAcmvIL-10). hIL-10 and
cmvIL-10 upregulated expression of Fcγ receptors, stimulated phagocytosis of IgG-opsonised erythrocytes and
decreased MHC class II (HLA-DR) expression on puriﬁed monocytes within 24 h. In contrast, LAcmvIL-10
decreased HLA-DR expression at later times (48 h and 72 h) but did not increase Fcγ receptor expression. We
conclude that cmvIL-10 promotes differentiation of monocytes towards a pro-phagocytic phenotype and that
LAcmvIL-10 does not affect monocytes by the same mechanism as cmvIL-10. The signiﬁcance of these
properties to cytomegalovirus pathogenesis is discussed.© 2009 Elsevier Inc. All rights reserved.IntroductionHuman cytomegalovirus (HCMV) is a ubiquitous β-herpesvirus
which infects human beings with a prevalence approaching 90–100%
in some populations (Mocarski et al., 2007). Primary infection by
HCMV is usually associated with no, or relatively mild, clinical
symptoms, however it is estimated to account for 8% of infectious
mononucleosis with occasionally severe systemic illness (ibid). Like
other herpesviruses, HCMV establishes a latent infection fromwhich it
can reactivate and which can cause severe disease in immunocom-
promised individuals such as AIDS patients and transplant recipients
(Sinzger and Jahn, 1996). The broad tropism of HCMV results in
infection of a wide range of cell types and, together with the
cytopathic nature of infection, a consequent large spectrum of overt
organ diseases including retinitis, pneumonitis and gastrointestinal
disease (Mocarski et al., 2007; Sinzger and Jahn, 1996).
During primary productive infection, HCMV is hematogenously
disseminated throughout the body. In acutely infected individuals,for Public Health and Medical
ralia. Fax: +61 3 9282 2100.
ski).
ll rights reserved.HCMV DNA or antigens have been detected in circulating endothelial
cells, lymphocytes,monocytes and neutrophils (Grefte et al.,1994,1993;
Gerna et al., 1992; Meyer-Konig et al., 1995). Quantitative analysis of
HCMV DNA in transplant recipients showed that neutrophils contrib-
uted themajority of the peripheral blood viral load, howevermonocytes
contained the highest percentage of infection having approximately 6
times the number of viral genomes per cell than neutrophils in these
individuals (Hassan-Walker et al., 2001). HCMV infection of monocytes
is efﬁcient but leads to an abortive infectionwhich allows early but not
lateHCMVantigenexpression,producing fewHCMVparticles (Frascaroli
et al., 2006). Productive infection depends on differentiation of
monocytes to monocyte-derived macrophages (Ibanez et al., 1991;
Lathey and Spector, 1991; Soderberg-Naucler et al., 2001) and/or
activation such as in the context of allogeneic T cell stimulation
(Soderberg-Naucler et al., 1997). The ability of cytokines such as IFNγ
to reactivateHCMV inmacrophage reservoirswas demonstrated in these
studies (Soderberg-Naucler et al., 2001). Theseobservations suggest that
monocytes may be an important reservoir allowing HCMV to establish
latent infection in the blood and acting as a source of virus in the context
of infection or transplantation.
Infection of monocytes with HCMV leads to altered monocyte
signalling and function including stimulation of proinﬂammatory
cytokine production and transcription factor expression (Yurochko
and Huang, 1999), altered monocyte differentiation characterised by
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particles (Gredmark et al., 2004), a decreased ability of HCMV infected
monocytes to present antigen to autologous lymphocytes which was
associated with decreased induction of MHC II expression by IFNγ
(Buchmeier and Cooper, 1989) and decreased chemokine receptor
expression and monocyte migration (Frascaroli et al., 2006). Recently,
microarray analysis of RNA from HCMV infected and uninfected
monocytes has suggested that HCMV infection skews monocyte
differentiation towards a proinﬂammatory M1 macrophage activation
state which is hypothesised to favour viral dissemination and
persistence (Chan et al., 2008).
HCMV encodes several proteins with immunomodulatory proper-
ties whichmay affect monocyte function and differentiation. Amongst
these are two alternatively spliced transcripts arising from the UL111A
gene which have been shown to encode homologues of interleukin 10
(IL-10) during the productive and latent phases of infection. These
transcripts have been denoted cmvIL-10 (Kotenko et al., 2000;
Lockridge et al., 2000) and latency associated LAcmvIL-10 (Jenkins
et al., 2004), and evidence for additional isoforms expressed during
productive infection have also been reported (Lin et al., 2008). Human
IL-10 (hIL-10) is a pleiotropic cytokine which exerts a number of
predominantly immunosuppressive functions such as down-
regulation of proinﬂammatory cytokine secretion andMHC expression
on myeloid cells (Moore et al., 2001). In monocytes, hIL-10 has been
reported to enhance phagocytosis by a variety of receptors including
CD14 (Lingnau et al., 2007) and complement and Fcγ receptors
(Capsoni et al., 1995; Capsoni et al., 1998). Consistent with these
observations, hIL-10 enhances Fcγ receptor (Allavena et al., 1998; te
Velde et al., 1992; Capsoni et al., 1998) and complement receptor
(Capsoni et al., 1995) expression on monocytes and alters their
differentiation by favouring a highly endocyticmacrophage phenotype
as opposed to an antigen presenting dendritic cell phenotype
(Allavena et al., 1998; te Velde et al., 1992). Humanmonocytes express
two Fcγ receptors which promote phagocytosis of particles opsonised
with IgG; Fcγ R1 (CD64) and Fcγ RIIA (CD32). In addition, a subset of
monocytes comprising approximately 10% of total human peripheral
bloodmonocytes also express Fcγ RIII (CD16) (Ziegler-Heitbrock et al.,
1993). These receptors differ in their afﬁnity for IgG and their
speciﬁcity for IgG subtypes (Hulett and Hogarth, 1994) and are
essential effector molecules for antibody-mediated immunity
(reviewed in Nimmerjahn and Ravetch (2008).
Like hIL-10, cmvIL-10 has been shown to exert a range of
immunosuppressive effects on myeloid cells including the capacity
to inhibit proinﬂammatory cytokine expression and peripheral blood
mononuclear cell (PBMC) proliferation, as well as to downregulate
MHC class I and MHC class II expression and inhibit the maturation of
dendritic cells (Chang et al., 2004; Raftery et al., 2004; Spencer et al.,
2002). cmvIL-10 also inhibits CD1 antigen expression (Raftery et al.,
2008) and decreases matrix metalloproteinase activity of cytotropho-
blasts (Yamamoto-Tabata et al., 2004). In contrast, the repertoire of
immunosuppressive properties of LAcmvIL-10 is less extensive, with
the only function to date being the capacity to downregulate MHC
class II, which appears to occur independently of the hIL-10 receptor
(Jenkins et al., 2008).
Given the critical importance of monocytes to HCMV pathogenesis,
and the role HCMV alteration of monocyte/macrophage function may
have in pathogenesis, we sought to determine whether cmvIL-10 and
LAcmvIL-10 inﬂuenced Fcγ receptor mediated phagocytosis. We show
that cmvIL-10 treatment of primary human monocytes induces the
expression of the three Fcγ receptors (CD16, 32 and 64) and increases
Fcγ receptor mediated phagocytosis. In contrast, LAcmvIL-10 does not
signiﬁcantly affect expression of these receptors, nor alter phagocy-
tosis of IgG opsonised targets. These results provide the ﬁrst
demonstration of a viral IL-10 homologue altering phagocytosis and
highlights a functional difference between HCMV-encoded homo-
logues of IL-10.Results
In order to determine the effect of HCMV homologues of hIL-10 on
monocyte phagocytic phenotype and function, monocytes were
puriﬁed from peripheral blood mononuclear cells by countercurrent
elutriation and incubated with saturating concentrations of recombi-
nant hIL-10, cmvIL-10 and LAcmvIL-10 for 24 h as previously described
(Jenkins et al., 2008). Expression of the Fcγ receptors CD16, CD32 and
CD64 was then measured by ﬂow cytometry (Fig. 1). Human IL-10
increased expression of all three Fcγ receptors (median expression
relative to control=1.27 (p=0.036) for CD16, 1.48 (p=0.001) for
CD32 and 1.59 (p=0.001) for CD64). This effect was observed with
cmvIL-10 for both CD32 and CD64 (median expression relative to
control=1.14 (p=0.028) for CD32,1.37 (p=0.008) for CD64) but not
for CD16. In contrast, LAcmvIL-10 had no effect on any of the three Fcγ
receptors at this time point. In addition, expression of the monocyte
marker CD14 and of MHC class II (HLA-DR) were also measured (data
not shown). Treatment of monocytes with hIL-10 and cmvIL-10
decreased cell surface HLA-DR expression within 24 h (median
expression=0.21 (p=0.001) and 0.42 (p=0.008) relative to control
incubations respectively) although LAcmvIL-10 had no effect on HLA-
DR expression at this relatively early time point (median expression
relative to control=1.19, p=0.26). Human IL-10, and both of the
HCMV IL-10 homologues, increased CD14 expression on monocytes
following 24 h incubation, demonstrating the biological activity of the
LAcmvIL-10 used in these experiments. It was concluded that cmvIL-
10 increased expression of Fcγ receptors CD32 and CD64 by
monocytes, but that LAcmvIL-10 did not.
Having shown that cmvIL-10 increases expression of Fcγ receptors,
we next determined whether treatment with HCMV-encoded IL-10
homologues affected Fcγ receptor mediated phagocytosis (Fig 2A).
Monocytes puriﬁed from peripheral blood of healthy donors were
treated for 24 h with either hIL-10, cmvIL-10 or LAcmvIL-10 before
phagocytosis of IgG opsonised, PKH26-labelled human red blood cells
(RBC) was measured. In experiments using monocytes puriﬁed from 5
independent donors, hIL-10 (median stimulation=72.1%, p=0.004)
and cmvIL-10 (median stimulation=43.5%, p=0.04) both stimulated
IgG-mediated phagocytosis whereas LAcmvIL-10 did not (Fig. 2B). Thus
the effect of hIL-10 and HCMV homologues of hIL-10 on phagocytosis
were consistent with their effects on Fcγ receptor expression. It was
concluded that like hIL-10, but unlike LAcmvIL-10, cmvIL-10 increased
Fcγ-receptor mediated phagocytosis by monocytes.
These experiments were performed at 24 h but as we had
previously shown that LAcmvIL-10 decreased HLA-DR expression on
monocytes at 48 h (Jenkins et al., 2008) we next examined the effect
of HCMV IL-10 homologues on monocyte phenotype at later time
points. In independent replicate experiments using monocytes from 2
different donors, LAcmvIL-10 decreased HLA-DR expression after 48 h
and 72 h but still did not increase Fcγ receptor expression (Table 1).
These data reveal a role for both cmvIL-10 and LAcmvIL-10 in
downmodulating HLA-DR expression by monocytes, but only cmvIL-
10 increases expression of phagocytic receptors and phagocytic
capacity by this cell type.
Discussion
In this study, we have shown that cmvIL-10, like hIL-10, speciﬁcally
alters monocyte phenotype by decreasing HLA-DR surface expression
and increasing expression and function of the phagocytic receptors for
the crystallisable fragment of human IgG, CD32A and CD64. One
interpretation of these results is that monocyte differentiation is
skewed towards a more phagocytic phenotype and away from an
antigen presentation phenotype. This interpretationwas strengthened
by showing that both hIL-10 and cmvIL-10 treatment promoted
phagocytosis of erythrocytes opsonised with IgG and is consistent
with observations that hIL-10 skews the GM-CSF plus IL-13 induced
22 A. Jaworowski et al. / Virology 391 (2009) 20–24differentiation ofmonocytes away from a dendritic cell like phenotype
towards a macrophage-like phenotype (Allavena et al., 1998). In
contrast, LAcmvIL-10, which is a homologue expressed during theFig. 2. The effect of IL-10 and cmv homologues of IL-10 on monocyte phagocytosis. (A)
Histograms showing phagocytosis of PKH26-labelled IgG-RBC by monocytes from a
representative donor treated with (a) hIL-10 (b) cmvIL-10 and (c) LAcmvIL-10. For each
panel, the negative phagocytic control (monocytes incubated at 4 °C with IgG-RBC) is
shown as black broken line. Phagocytosis of unopsonised RBC is shown as a broken line
in purple. The red solid line represents phagocytosis of IgG-RBC by control monocytes
and the blue histogram represents phagocytosis of IgG-RBC by monocytes incubated
with hIL-10 or cmv IL-10 homologue. (B) Fcγ receptor mediated phagocytosis by
monocytes from 5 independent donors treated for 24 h with hIL-10 (black circles),
cmvIL-10 (open circles) or LA cmvIL-10 (open squares). The % stimulation was
calculated by subtracting % phagocytosis of the appropriate control monocytes
(incubated with puriﬁed, mock transformed E. coli extracts as described in Materials
and methods) from that of the treated monocytes and expressing as a ratio to
phagocytosis of the controls. Data were analysed using non-parametric Mann Whitney
test. p valuesb0.05 were considered signiﬁcant.latent phase of infection, did not increase expression of Fcγ receptors
and decreased HLA-DR expression only at later time points. Thus this
study extends our previous data demonstrating that LAcmvIL-10 does
not retain the full repertoire of immunomodulatory functions encoded
by cmvIL-10 or hIL-10 on myeloid cells or B cells (Jenkins et al., 2008;
Spencer et al., 2008), highlighting different functions of these virally
encoded hIL-10 homologues. The inability of LAcmvIL-10 to stimulate
monocyte phagocytosis like cmvIL-10 may be a consequence of the
truncated C-terminus of LAcmvIL-10 (Jenkins et al., 2004) which
removes regions important for interacting with and signalling via the
hIL-10 receptor (Jones et al., 2002). Indeed, LAcmvIL-10 has been
reported to modulate HLA-DR expression on monocytes in a manner
which may be independent of the hIL-10 receptor (Jenkins et al.,
2008), which may explain the different kinetics of HLA-DR down
modulation observed with LAcmvIL-10 and cmvIL-10 in the present
study.
Human IL-10 has previously been shown to upregulate Fcγ
receptor I (CD64) expression on peripheral blood monocytes and
phagocytosis of IgG opsonised erythrocytes (te Velde et al., 1992;
Capsoni et al., 1995). In these studies, however, unlike our present data
with hIL-10, no increase in Fcγ receptor II or III expression (CD32 and
CD16 respectively) was observed. It is difﬁcult to compare our dataFig. 1. Expression of selected surface markers on monocytes stimulated with hIL-10 or
cmv homologues of IL-10. Elutriated monocytes were cultured in hIL-10 or CMV
encoded IL-10 homologues for 24 h, and the surface expression of CD16, CD32 and CD64
was then measured by immunostaining followed by ﬂow cytometric analysis. Net MFI
values were calculated by subtracting the median ﬂuorescence of the isotype control
from that of the antibody-stained sample; relative MFI values were calculated by
dividing the net MFI of IL-10 treated monocytes by the net MFI of the relevant control.
hIL-10 (left column), cmvIL-10 (middle column) LAcmvIL-10 (right column). Data were
normalised to the expression measured in control incubations using puriﬁed, mock
transformed E. coli extracts as described in Materials and methods (dotted line). Unique
symbols are shown for each donor tested, and bars represent median values. Data were
analysed using non-parametric Mann Whitney test. p values are treated versus
untreated control cells; p values b0.05 were considered signiﬁcant.
Table 1
Effect of hIL-10 and LAcmvIL-10 on monocyte phenotype at 48 and 72 h.
CD14 Relative MFI CD16 Relative MFI CD32 Relative MFI CD64 Relative MFI HLA-DRRelativeMFI
48 h 72 h 48 h 72 h 48 h 72 h 48 h 72 h 48 h 72 h
Human IL-10 Experiment 1 2.17 2.51 1.91 3.32 2.35 2.03 2.99 3.16 0.32 0.26
Experiment 2 1.93 2.55 2.05 4.48 1.38 3.02 2.21 12.24 0.18 0.55
LAcmv IL-10 Experiment 1 2.90 2.35 1.38 1.74 1.08 1.06 0.76 0.57 0.44 0.45
Experiment 2 3.00 2.15 1.12 1.09 0.72 0.81 0.70 1.04 0.16 0.25
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was shown in their paper. The effect of hIL-10 on Fcγ receptor II and III
expression is relatively modest and donor dependent and may have
been missed in their study. In the study reported by Capsoni et al.
(1995) monocytes were cultured in RPMI containing 10% foetal calf
serum, whereas we used Iscoves medium supplemented with 10%
pooled human serum, a source of human M-CSF. Monocytes require a
source of human M-CSF (or GM-CSF) for optimal survival which is
lacking in foetal calf serum (SM Crowe, unpublished data). The
response to hIL-10 may have been different in the two culture
conditions or the effect of hIL-10 on monocytes may be modulated
byM-CSF. This is consistent with the observation that hIL-10 increases
expression of all three receptors (Fcγ RI, II, III) in monocytes cultured
with exogenous M-CSF (Hashimoto et al., 1997).
The fact that cmvIL-10 increases both the expression and function
of Fcγ receptors and down-modulates HLA-DR expression shows that
HCMV alters the maturation pathway of monocytes in a similar
manner to hIL-10 (Allavena et al., 1998). The advantage this confers for
HCMV infection needs to be further investigated, however such
activity may be advantageous to the spread of the virus if it
subsequently suppresses immune responses to infection. Promoting
a macrophage-like differentiation pathway in contrast to a dendritic
cell pathway in infected tissues may prevent the migration of HCMV
infected monocytes to draining lymph nodes or alter their ability to
subsequently present viral antigens and stimulate T lymphocytes. In
this context, it has been shown that the injection of suppressive
cytokines such as hIL-10 prior to dendritic cell migration in a human
skin explant model alters the subsequent maturation of dendritic cells
to a CD14+ immature phenotype unable to efﬁciently stimulate Tcells
(de Gruijl et al., 2006). The ability of HCMV-encoded homologues of
hIL-10 to similarly inhibit monocyte function remains to be demon-
strated. Given that monocytes are not productively infected with
HCMV, and are required to differentiate to macrophages before being
permissive to virus replication (Soderberg-Naucler et al., 2001), they
would not be expected to secrete appreciable amounts of cmvIL-10
themselves. The source of this protein in infected tissues would
therefore presumably be productively infected cell types such as
endothelial cells ormacrophages, resulting in a bystander effect on the
monocytes. An important goal of future studies will be analysis of
recombinant viruses lacking the capacity to express cmvIL-10 during
productive infection of phagocytic cells such as macrophages so as to
deﬁne the role of this viral protein on Fcγ receptor expression and
phagocytosis in the context of direct virus infection.Materials and methods
Materials
All antibodies used for ﬂow cytometric analysis (CD14-FITC, CD16-
PE-Cy5, CD32-PE, CD64-FITC and HLA-DR-PE) were purchased from
BD Pharmingen. Recombinant hIL-10 was purchased from R&D
Systems, cmvIL-10 and LAcmvIL-10 were expressed and puriﬁed in
house as described elsewhere (Jenkins et al., 2008). PKH26 was
purchased from Sigma.Monocyte puriﬁcation
Buffy packs were obtained from the Australian Red Cross Blood
Service from donors testing negative for HTLV, HIV, HBV and HCV
antigens. Peripheral bloodmononuclear cells (PBMC)were isolated by
Ficoll density gradient centrifugation and monocytes puriﬁed from
this cell fraction by countercurrent elutriation at 2500 rpm,12 °C using
a Beckman J-6M/E centrifuge equipped with a JE 5.0 rotor. Cells were
loaded into the elutriation chamber at a ﬂow rate of 12 ml/min,
lymphocytes eluted by extensive washing at 14–16 ml/min then
monocyteswere eluted at a ﬂow rate of 18ml/min. Purity of elutriated
monocytes was typically as assessed by light scatter analysis using
ﬂow cytometry, with a viability of N99%, assessed using trypan blue
exclusion.
Culture of monocytes
Puriﬁed monocytes were cultured at a concentation of 2×106/ml
in complete Iscoves modiﬁed Dulbecco's medium supplemented with
10% pooled heat-inactivated human serum (IH10) in 4 ml polypro-
pylene tubes (Falcon) at 37 °C for 24 h unless otherwise indicated. hIL-
10 was added at a ﬁnal concentration of 10 ng/ml and IL-10
homologues at a ﬁnal concentration of 100 ng/ml. Untreated cells
incubated under identical conditions were used as a control for hIL-10.
The IL-10 homologues used in this study were derived from
transformed E. coli cultures and puriﬁed by ion exchange chromato-
graphy as previously described (Jenkins et al., 2008). To ensure that
changes in monocyte phenotype or function were not due to factors
present in the column eluate such as co-puriﬁed E. coli protein, mock
transformed E. coli samples were carried through the same puriﬁca-
tion protocol in parallel with each homologue preparation, and equal
volumes of the eluate used as a control. For all measurements made
using HCMV homologues data were expressed as relative to the data
obtained using monocytes treated with this control.
Monocyte phenotype analysis
Cells were washed once in Ca2+/Mg2+ free phosphate buffered
saline containing 1% new born calf serum (HyClone) plus 2 mM EDTA
(FACS wash), then incubated with saturating concentrations of the
relevant conjugated antibodies at 4 °C for 30 min. After staining, cells
werewashed once in FACSwash then ﬁxedwith 2% paraformaldehyde
and analysed by ﬂow cytometry using a FACSCalibur (BD Biosciences)
capturing a minimum of 5000 events per condition. Data were
analysed using WEHI FACS Lab Weasel Software.
Flow cytometric phagocytosis assay
Puriﬁed monocytes, resuspended in RPMI medium supplemented
with 2% new born calf serum, were aliquoted into 4 ml polypropylene
tubes (0.1 ml, 1×106 cells/ml) and incubated with PKH26-labelled
human red blood cells (RBC) opsonised with 1:2000 rabbit anti
human red blood cell antibody (ICN Cappel) at a target to cell ratio of
10:1. Phagocytosis was allowed to proceed at 37 °C for 30 min then
tubes were plunged into ice and uningested RBC were lysed by
24 A. Jaworowski et al. / Virology 391 (2009) 20–24incubation for 10 min in FACS lysing solution (BD Biosciences).
Monocytes were then washed once with ice cold FACS wash and ﬁxed
with 2% formaldehyde before ﬂow cytometric analysis. As a negative
control, monocytes were incubated with IgG opsonised PKH26-
labelled RBC at 4 °C for 30 min or incubated with unopsonised
PKH26-labelled RBC at 37 °C for 30 min. Internalised RBC were
quantiﬁed by measuring PKH26 ﬂuorescence in FL3. Baseline separa-
tion was achieved between cells which had ingested RBC and those
which had not, so the percent phagocytosis was calculated from the
number of events in each peak. The value of background phagocytosis,
measured in the 4 °C incubated sample, was subtracted to obtain a net
phagocytosis value. A stimulation index was calculated by comparing
Fc phagocytosis to that of the relevant mock treated control cells.
Statistical treatment of data
Data were analysed using the one sample median test for non-
parametric data and Stata software. pb0.05 was considered signiﬁcant.
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